TFS Capital’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-40,920
| Closed | -$104K | – | 150 |
|
|
2017
Q2 | $104K | Buy |
40,920
+9,882
| +32% | +$25.1K | 0.04% | 541 |
|
|
2017
Q1 | $81K | Sell |
31,038
-23,035
| -43% | -$60.1K | 0.03% | 606 |
|
|
2016
Q4 | $165K | Buy |
54,073
+21,652
| +67% | +$66.1K | 0.04% | 566 |
|
|
2016
Q3 | $88K | Sell |
32,421
-111,656
| -77% | -$303K | 0.02% | 668 |
|
|
2016
Q2 | $412K | Buy |
+144,077
| New | +$412K | 0.08% | 434 |
|
|
2015
Q3 | – | Sell |
-98,648
| Closed | -$562K | – | 957 |
|
|
2015
Q2 | $562K | Buy |
+98,648
| New | +$562K | 0.05% | 485 |
|
|
2013
Q4 | – | Sell |
-55,827
| Closed | -$223K | – | 1535 |
|
|
2013
Q3 | $223K | Sell |
55,827
-82,783
| -60% | -$331K | 0.01% | 1217 |
|
|
2013
Q2 | $494K | Buy |
+138,610
| New | +$494K | 0.02% | 900 |
|